Skip to main content

Are you Town & Country Compounding - We Compound Quality? Claim this listing to update your information and add verification.

Claim listing
503A Pharmacy
Verified listing

Verified

Town & Country Compounding - We Compound Quality

Pennsylvania, United States

No rating available

Town & Country Compounding is a 503A pharmacy that creates personalized compounded medications across 22 states, offering specialties including low-dose naltrexone, ketamine, pain management, women's and men's health formulations, and methylene blue. They serve both patients and prescribers, with compounding protocols designed to support treatment outcomes in areas where standard prescriptions may not fit individual needs. The pharmacy also offers supplements, educational events, and partnerships with practitioners in integrative and interventional medicine.

Provider Details

503A Compounding Pharmacy

Prescriptions are required. Compounds are prepared to order for individual patients and cannot be sold in bulk without a physician order.

Coverage

Country
United States
State
Pennsylvania
Telehealth
Not available
Regions Served
United States

Compliance

Verified Listing
Yes
Compliance Type
503A Compounding

Verification & FDA Records

Verified listing· · 503A Compounding Pharmacy

Report an error

Town & Country Compounding - We Compound Quality

Use this form to flag incorrect data, outdated information, or a misattributed finding. Our team reviews every report.

Related providers

Track this provider

Know when Town & Country Compounding - We Compound Quality changes.

Get an email when their verification status, reviews, or peptide list is updated.

Listed on PeptideBase badge

Add this badge to your website

Profile last updated

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.

Free Guide

The Peptide Research Digest

Get our free provider vetting guide — plus weekly research briefings on peptide sourcing, COA verification, and clinical developments.

No spam.